Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Patil, D. Taur, R. Patil, D. Ahirwar (Malegaon (Bk) Tal- Baramati, Kharadi, Pune, Bilaspur, India). In-vitro bronchodilator activity clitoria ternatea and A. precatorius. Eur Respir J 2013; 42: Suppl. 57, 676

Member's Comments

No comment yet.

Related content which might interest you: Evaluation of bronchodilator activity of A. precatorius leaves Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 Bioactivity-guided isolation of bronchodilator fraction from clitoria ternatea roots Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013 Zizyphus spina-christi for the management of adult asthma Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013 Occupational asthma to ’the miracle tree’ (Moringa oleifera): First description Source: International Congress 2015 – Occupational disease: clinical cases and series Year: 2015 Sakuranetin treatment from baccharis retusa reduces acid mucus in a murine model of asthma Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action Year: 2016 Effects of rosemary and platanus extracts on asthmatic subjects resistant to traditional treatments Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013 Protein identification of two allergens of boletus edulis causing occupational asthma Source: Annual Congress 2013 –Environmental and occupational respiratory diseases: new exposure assessment methods, experimental exposure in animal and humans and mechanisms Year: 2013 Identification of IgE reactive proteins from pollen of Lagerstroemia speciosa and spathodea campanulata – Two avenue trees of West Bengal Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015 Assessment of anti-tuberculosis activity of extracts of cinnamomum verum and solanun surattense along with isoniazid Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016 A combination of thyme and primula dry extracts possesses antitussive activity and inhibits leukotriene formation Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013 Potential effect of the extract of zataria multiflora and its consituent carvacrol on lung inflammation of sensitized guinea pigs Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013 Asthma nervosum Source: Eur Respir J 2011; 38: 994 Year: 2011 In vitro characterization of a novel inhaled PI3Kd inhibitor LAS194223 Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 The effect of oligomeric proanthocyanidin on airway microenvironment in asthma Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action Year: 2016 In vitro profile of the new inhaled pan-JAK inhibitor LAS194046 Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 Study of antioxidant use in patients with asthma exacerbations Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013 Comparison of the in vitro performance of originator and generic drug-combination dry powder inhalers Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 When needed use of inhaled steroids in children with asthma Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management Year: 2014 Clinical effectiveness of anti-IgE therapy in severe asthma with fungus sensitization Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 Bronchodilator effect of a novel inhaled dual PDE3/4 inhibitor, RPL554, in mild allergic asthma & rhinitis Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics Year: 2013